FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2560615235> ?p ?o ?g. }

• W2560615235 endingPage "163" @default.
• W2560615235 startingPage "153" @default.
• W2560615235 abstract "Tacrolimus for the management of psoriasis: clinical utility and place in therapy Nina Malecic,1,2 Helen Young2 1Manchester Medical School, 2The Dermatology Research Centre, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK Abstract: Psoriasis affects 1%–3% of the population in the United Kingdom and can convey significant detriment to the physical and mental health of sufferers. Plaques of psoriasis typically affect the extensor skin surfaces and scalp. Less frequently inverse psoriasis can affect more sensitive skin such as the face, genitals, and intertriginous areas. Psoriasis is incurable, but there are a range of treatment modalities that can be used to manage the condition. Treatment options include topical preparations, phototherapy, systemic therapy, and biological agents. Tacrolimus is a macrolide calcineurin inhibitor licensed for immunosuppression in transplant patients and topical administration in atopic dermatitis. Tacrolimus administered orally and in topical form has been shown to produce successful outcomes in patients with psoriasis. Topical tacrolimus is particularly effective for inverse psoriasis, which is likely to be due to the reduced level of induration seen in these psoriatic lesions, which allows greater skin penetrance, compared with hyperkeratotic plaques of psoriasis on the body. It is also notable that the areas affected by inverse psoriasis are more susceptible to adverse effects of topical corticosteroid therapy, and thus a topical preparation without the risk of skin atrophy, telangiectasia, and striae could be a valuable addition to current topical treatment options. Oral tacrolimus has shown efficacy in the treatment of severe, refractory psoriasis. Compared to ciclosporin, systemic tacrolimus may be more suited to a patient population with increased cardiovascular risk. This review will draw together the current literature on topical and oral tacrolimus for the treatment of psoriasis. Efficacy and safety have been evaluated by case reports and randomized controlled trials and comparisons have been made between tacrolimus therapy and standard treatment. Keywords: tacrolimus, psoriasis, topical therapy, oral treatment" @default.
• W2560615235 created "2016-12-16" @default.
• W2560615235 creator A5064873632 @default.
• W2560615235 creator A5082107704 @default.
• W2560615235 date "2016-12-01" @default.
• W2560615235 modified "2023-10-18" @default.
• W2560615235 title "Tacrolimus for the management of psoriasis: clinical utility and place in therapy" @default.
• W2560615235 cites W145744642 @default.
• W2560615235 cites W1521483346 @default.
• W2560615235 cites W1562559889 @default.
• W2560615235 cites W1569848357 @default.
• W2560615235 cites W1592567691 @default.
• W2560615235 cites W1792727815 @default.
• W2560615235 cites W192649796 @default.
• W2560615235 cites W1940293689 @default.
• W2560615235 cites W1968958817 @default.
• W2560615235 cites W1971491767 @default.
• W2560615235 cites W1974141690 @default.
• W2560615235 cites W2002718403 @default.
• W2560615235 cites W2003810928 @default.
• W2560615235 cites W2007179975 @default.
• W2560615235 cites W2038449211 @default.
• W2560615235 cites W2040528185 @default.
• W2560615235 cites W2046412737 @default.
• W2560615235 cites W2054336930 @default.
• W2560615235 cites W2057240156 @default.
• W2560615235 cites W2059095993 @default.
• W2560615235 cites W2060078400 @default.
• W2560615235 cites W2060530479 @default.
• W2560615235 cites W2064323006 @default.
• W2560615235 cites W2069770771 @default.
• W2560615235 cites W2085117561 @default.
• W2560615235 cites W2102883114 @default.
• W2560615235 cites W2106686862 @default.
• W2560615235 cites W2107157774 @default.
• W2560615235 cites W2107531925 @default.
• W2560615235 cites W2121126920 @default.
• W2560615235 cites W2123790562 @default.
• W2560615235 cites W2128899257 @default.
• W2560615235 cites W2129827777 @default.
• W2560615235 cites W2131605956 @default.
• W2560615235 cites W2135834476 @default.
• W2560615235 cites W2146128398 @default.
• W2560615235 cites W2149818303 @default.
• W2560615235 cites W2166793660 @default.
• W2560615235 cites W2172350744 @default.
• W2560615235 cites W2418407232 @default.
• W2560615235 cites W2418792808 @default.
• W2560615235 cites W2424206213 @default.
• W2560615235 cites W2512123805 @default.
• W2560615235 cites W2615917626 @default.
• W2560615235 cites W4233081484 @default.
• W2560615235 cites W73865498 @default.
• W2560615235 cites W961857829 @default.
• W2560615235 cites W2039436098 @default.
• W2560615235 doi "https://doi.org/10.2147/ptt.s101233" @default.
• W2560615235 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5683124" @default.
• W2560615235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29387602" @default.
• W2560615235 hasPublicationYear "2016" @default.
• W2560615235 type Work @default.
• W2560615235 sameAs 2560615235 @default.
• W2560615235 citedByCount "22" @default.
• W2560615235 countsByYear W25606152352018 @default.
• W2560615235 countsByYear W25606152352019 @default.
• W2560615235 countsByYear W25606152352020 @default.
• W2560615235 countsByYear W25606152352021 @default.
• W2560615235 countsByYear W25606152352022 @default.
• W2560615235 countsByYear W25606152352023 @default.
• W2560615235 crossrefType "journal-article" @default.
• W2560615235 hasAuthorship W2560615235A5064873632 @default.
• W2560615235 hasAuthorship W2560615235A5082107704 @default.
• W2560615235 hasBestOaLocation W25606152351 @default.
• W2560615235 hasConcept C126322002 @default.
• W2560615235 hasConcept C128057223 @default.
• W2560615235 hasConcept C141071460 @default.
• W2560615235 hasConcept C16005928 @default.
• W2560615235 hasConcept C2776009542 @default.
• W2560615235 hasConcept C2776028589 @default.
• W2560615235 hasConcept C2777645581 @default.
• W2560615235 hasConcept C2778329239 @default.
• W2560615235 hasConcept C2779134260 @default.
• W2560615235 hasConcept C2780564577 @default.
• W2560615235 hasConcept C2908647359 @default.
• W2560615235 hasConcept C2909675724 @default.
• W2560615235 hasConcept C2911091166 @default.
• W2560615235 hasConcept C71924100 @default.
• W2560615235 hasConcept C99454951 @default.
• W2560615235 hasConceptScore W2560615235C126322002 @default.
• W2560615235 hasConceptScore W2560615235C128057223 @default.
• W2560615235 hasConceptScore W2560615235C141071460 @default.
• W2560615235 hasConceptScore W2560615235C16005928 @default.
• W2560615235 hasConceptScore W2560615235C2776009542 @default.
• W2560615235 hasConceptScore W2560615235C2776028589 @default.
• W2560615235 hasConceptScore W2560615235C2777645581 @default.
• W2560615235 hasConceptScore W2560615235C2778329239 @default.
• W2560615235 hasConceptScore W2560615235C2779134260 @default.
• W2560615235 hasConceptScore W2560615235C2780564577 @default.
• W2560615235 hasConceptScore W2560615235C2908647359 @default.

• next